This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Squamous Cell Carcinoma of Head and Neck
and you are
over 18
years old
This is a medium phase trial determining
the safety and dosage of the new treatment, as well as its efficacy.
Show me locations

The purpose

The purpose of this study is to identify a dose of P276-00 that can be safely administered along with Radiation and to examine safety and efficacy of the combination in treatment of advanced head and neck cancer.

Provided treatments

  • Drug: P276-00
  • Radiation: External beam radiotherapy (EBRT)
Tris trial is registered with FDA with number: NCT00899054. The sponsor of the trial is Piramal Enterprises Limited and it is looking for 23 volunteers for the current phase.
Official trial title:
An Open Label, Multicenter Phase I/II Study Of Selective Cyclin Dependent Kinase Inhibitor P276-00 In Combination With Radiation In Subjects With Recurrent And/Or Locally Advanced Squamous Cell Carcinoma Of Head And Neck